METHYL 6-BROMO-1-METHYL-2-OXO-2,3-DIHYDRO-1H-INDOLE-4-CARBOXYLATE, 95.0%, 1g

4-(4-Methyl-piperidin-1-yl)-benzoic acid, 10g

1,7-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, 98%, 5g

5-AMINOQUINOLINE-8-CARBONITRILE, 95.0%, 100mg

(R,R)-(-)-2,3-Bis(tert-butylmethylphosphino)quinoxaline>98.0%(HPLC)100mg

5-Bromo-1,7-naphthyridin-8-ol, 95.0%, 100mg

3,5-Dimethylbenzeneboronic acid, 98.0%, 100g

3,5-Dibromo-4-cyanopyridine, 97.0%, 5g

(S)-2-(Chloromethyl)-1-methylpyrrolidine hydrochloride, 97%, 1g

2-Methyl-5-oxo-2,5-dihydro-1H-pyrazole-3-carboxylic acid, 97%, 100mg

2-PYRAZINECARBOXAMIDE, 5-[2-METHOXY-4-[[[2-(TETRAHYDRO-2H-PYRAN-4-YL)ETHYL]AMINO]METHYL]PHENOXY]-, 95.0%, 1g

N-Ethylethylenediamine>99.0%(GC)25mL

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(2-(tert-butoxy)-2-oxoethyl)phenyl)propanoic acid, 97%, 50mg